Skip to content

Botulinum toxin for the treatment of anal fistulae - a double blinded randomized trial

Botulinum toxin for the treatment of anal fistulae - a double blinded randomized trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000094976
Enrollment
6
Registered
2020-02-04
Start date
2020-06-29
Completion date
2025-12-31
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is a double blinded randomized trial of Botox injection for the treatment of complex anal fistulae. All patients will have a Seton drain placed at their initial surgery. After six weeks they will be randomized to either Botox injection to the anal sphincter or placebo as well as (in both groups) removal of the Seton drain. Patients will be followed up at 3,12 and 24 weeks to assess healing of the fistula.

Interventions

This is a blinded randomized trial of Botox injection with removal of the Seton drain and de- epithelialisation of the tract compared with Seton removal and de- epithelialisation alone for the treatment of complex anal fistulae. Dose of Botox: 2 X 40iU injections to the anal sphincters as a single administratio. This will be performed by the patient's treating surgeon. This procedure takes approximately thee minutes. Follow up will be done by a speicalist surgeon. The fistula will be judged to h

This is a blinded randomized trial of Botox injection with removal of the Seton drain and de- epithelialisation of the tract compared with Seton removal and de- epithelialisation alone for the treatment of complex anal fistulae. Dose of Botox: 2 X 40iU injections to the anal sphincters as a single administratio. This will be performed by the patient's treating surgeon. This procedure takes approximately thee minutes. Follow up will be done by a speicalist surgeon. The fistula will be judged to have healed (primary endpoint of the study) if the following criteria are met: • The external opening has healed. • The internal opening cannot be palpated on digital rectal examination. • The patient does not complain of any ongoing drainage from the fistula site.

Sponsors

Dept Surgery, Deakin University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Complex anal fistula with Seton drain in situ

Exclusion criteria

• Patients with known Crohn’s disease of anorectal malignancy. • Patients with rectovaginal or anovaginal fistulae. • Patients with known generalised musculoskeletal disease. • Patients with known sensitivity to Botox. • Pregnant or breast- feeding women.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026